Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)

M. Hiligsmann*, D. Cornelissen, B. Vrijens, B. Abrahamsen, N. Al-Daghri, E. Biver, M. L. Brandi, O. Bruyere, N. Burlet, C. Cooper, B. Cortet, E. Dennison, A. Diez-Perez, A. Gasparik, A. Grosso, P. Hadji, P. Halbout, J. A. Kanis, J. M. Kaufman, A. LaslopS. Maggi, R. Rizzoli, T. Thomas, S. Tuzun, M. Vlaskovska, J. Y. Reginster

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2155-2165
Number of pages11
JournalOsteoporosis International
Volume30
Issue number11
DOIs
Publication statusPublished - Nov 2019

Keywords

  • Adherence
  • Determinants
  • Osteoporosis
  • Persistence
  • Solutions
  • SHARED DECISION-MAKING
  • MEDICATION ADHERENCE
  • FRACTURE RISK
  • POSTMENOPAUSAL WOMEN
  • PERSISTENCE
  • CARE
  • PATIENT
  • INTERVENTIONS
  • BISPHOSPHONATES
  • NONADHERENCE

Cite this